MY134340A - Pharmaceutical formulation having a masked taste and method for the production thereof - Google Patents

Pharmaceutical formulation having a masked taste and method for the production thereof

Info

Publication number
MY134340A
MY134340A MYPI20022250A MYPI20022250A MY134340A MY 134340 A MY134340 A MY 134340A MY PI20022250 A MYPI20022250 A MY PI20022250A MY PI20022250 A MYPI20022250 A MY PI20022250A MY 134340 A MY134340 A MY 134340A
Authority
MY
Malaysia
Prior art keywords
pharmaceutical formulation
production
taste
masked taste
masked
Prior art date
Application number
MYPI20022250A
Other languages
English (en)
Inventor
Philippe Becourt
Josiane Chauvin
Detlev Schwabe
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of MY134340A publication Critical patent/MY134340A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MYPI20022250A 2001-06-21 2002-06-17 Pharmaceutical formulation having a masked taste and method for the production thereof MY134340A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0108157A FR2826274B1 (fr) 2001-06-21 2001-06-21 Formulation pharmaceutique au gout masque et son procede de preparation

Publications (1)

Publication Number Publication Date
MY134340A true MY134340A (en) 2007-12-31

Family

ID=8864587

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20022250A MY134340A (en) 2001-06-21 2002-06-17 Pharmaceutical formulation having a masked taste and method for the production thereof

Country Status (41)

Country Link
US (2) US7138138B2 (enExample)
EP (1) EP1401397B1 (enExample)
JP (1) JP4880871B2 (enExample)
CN (1) CN1239149C (enExample)
AP (1) AP1595A (enExample)
AR (1) AR036096A1 (enExample)
AT (1) ATE290366T1 (enExample)
AU (1) AU2002329311B2 (enExample)
BG (1) BG66314B1 (enExample)
BR (1) BRPI0208998A2 (enExample)
CA (1) CA2452239C (enExample)
CO (1) CO5540278A2 (enExample)
CZ (1) CZ299947B6 (enExample)
DE (1) DE60203178T2 (enExample)
EA (1) EA006016B1 (enExample)
EC (1) ECSP034915A (enExample)
ES (1) ES2236574T3 (enExample)
FR (1) FR2826274B1 (enExample)
GT (2) GT200200115AA (enExample)
HR (1) HRP20031067B1 (enExample)
HU (1) HUP0400799A3 (enExample)
IL (2) IL159404A0 (enExample)
JO (1) JO2325B1 (enExample)
MA (1) MA27042A1 (enExample)
MX (1) MXPA03011756A (enExample)
MY (1) MY134340A (enExample)
NO (1) NO332258B1 (enExample)
NZ (1) NZ530042A (enExample)
OA (1) OA12635A (enExample)
PA (1) PA8548301A1 (enExample)
PE (1) PE20030201A1 (enExample)
PL (1) PL202090B1 (enExample)
PT (1) PT1401397E (enExample)
SK (1) SK285865B6 (enExample)
SV (1) SV2003001098A (enExample)
TN (1) TNSN03141A1 (enExample)
TW (1) TWI228049B (enExample)
UA (1) UA77960C2 (enExample)
UY (1) UY27341A1 (enExample)
WO (1) WO2003000225A2 (enExample)
ZA (1) ZA200309479B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7384921B2 (en) * 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
GB2419094A (en) * 2004-10-12 2006-04-19 Sandoz Ag Pharmaceutical composition of unpleasnt tasing active substances
FR2882522B1 (fr) * 2005-02-25 2007-04-13 Aventis Pharma Sa Composition pharmaceutique solide comprenant de la telithromycine
US7384922B2 (en) * 2005-05-04 2008-06-10 Enanta Pharmaceuticals, Inc. 6-11 bridged oxime erythromycin derivatives
US20060264386A1 (en) * 2005-05-17 2006-11-23 Rongqi Sun Pharmaceutical formulations of 6-11 bicyclic ketolide derivatives and related macrolides and methods for preparation thereof
US20090011007A1 (en) * 2006-02-03 2009-01-08 Evonik Roehm Gmbh Pharmaceutical Compositions Containing Mixtures of Polymers and Active Agents Poorly Soluble in Water
WO2007108010A2 (en) * 2006-03-21 2007-09-27 Jubilant Organosys Limited Taste masked pharmaceutical composition for oral solid dosage form and process for preparing the same using magnesium aluminium silicate
US20080181932A1 (en) * 2007-01-30 2008-07-31 Drugtech Corporation Compositions for oral delivery of pharmaceuticals
KR100935893B1 (ko) * 2007-09-11 2010-01-07 국방과학연구소 1,1'-다이메틸-5,5’-바이테트라졸의 합성방법
CA2703475A1 (en) 2007-10-25 2009-04-30 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
DK2379635T3 (en) 2008-12-16 2016-12-05 Carlsberg As Cellulosic polymer material
KR20140139083A (ko) 2012-03-27 2014-12-04 셈프라 파마슈티컬스, 인크. 마크롤라이드계 항생제를 투여하기 위한 비경구 제제
DE102012014848A1 (de) * 2012-07-27 2012-10-31 Heilerde-Gesellschaft Luvos Just GmbH & Co. KG Heilerde-Zubereitung
AU2015301154A1 (en) * 2014-08-05 2017-02-23 Cempra Pharmaceuticals, Inc. Powder oral suspension formulations of antibacterial agents
US10982177B2 (en) 2017-09-18 2021-04-20 The Clorox Company Cleaning wipes with particular lotion retention and efficacy characteristics
CN114209661B (zh) * 2022-02-21 2022-04-29 北京罗诺强施医药技术研发中心有限公司 呈细粒形式的固体药物组合物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2930409A1 (de) * 1979-07-26 1981-02-12 Bayer Ag Spruehtrocknung von mikrokapseldispersionen
JPS63150220A (ja) * 1986-12-15 1988-06-22 Dainippon Pharmaceut Co Ltd 経口用固形製剤の製造方法
US4808411A (en) * 1987-06-05 1989-02-28 Abbott Laboratories Antibiotic-polymer compositions
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
ZA945944B (en) * 1993-08-13 1996-02-08 Eurand America Inc Procedure for encapsulating nsaids
AUPN969796A0 (en) * 1996-05-07 1996-05-30 F.H. Faulding & Co. Limited Taste masked liquid suspensions
US6153220A (en) * 1997-10-03 2000-11-28 Elan Corporation, Plc Taste-masked formulations
IN191239B (enExample) * 1999-06-11 2003-10-11 Ranbaxy Lab Ltd
US6555569B2 (en) * 2000-03-07 2003-04-29 Pfizer Inc. Use of heteroaryl substituted N-(indole-2-carbonyl-) amides for treatment of infection
US6740642B2 (en) * 2000-08-22 2004-05-25 Basilea Parmaceutica Ag Macrolides with antibacterial activity

Also Published As

Publication number Publication date
OA12635A (fr) 2006-06-15
EA006016B1 (ru) 2005-08-25
CZ299947B6 (cs) 2009-01-07
EP1401397B1 (fr) 2005-03-09
EP1401397A2 (fr) 2004-03-31
PA8548301A1 (es) 2003-09-05
IL159404A (en) 2007-08-19
HUP0400799A3 (en) 2012-08-28
PL366803A1 (en) 2005-02-07
BRPI0208998A2 (pt) 2017-06-06
CZ20033441A3 (en) 2004-03-17
WO2003000225A3 (fr) 2003-03-13
GT200200115AA (es) 2005-01-12
IL159404A0 (en) 2004-06-01
TWI228049B (en) 2005-02-21
CA2452239C (fr) 2011-07-19
GT200200115A (es) 2003-02-27
ECSP034915A (es) 2004-02-26
PL202090B1 (pl) 2009-06-30
ZA200309479B (en) 2005-04-26
DE60203178T2 (de) 2006-01-26
JP2004534810A (ja) 2004-11-18
HRP20031067B1 (en) 2011-10-31
UA77960C2 (en) 2007-02-15
US7138138B2 (en) 2006-11-21
PE20030201A1 (es) 2003-03-12
DE60203178D1 (de) 2005-04-14
PT1401397E (pt) 2005-05-31
MXPA03011756A (es) 2004-07-01
ES2236574T3 (es) 2005-07-16
HRP20031067A2 (en) 2004-04-30
JP4880871B2 (ja) 2012-02-22
JO2325B1 (en) 2006-06-28
TNSN03141A1 (fr) 2005-12-23
SK285865B6 (sk) 2007-10-04
HK1067558A1 (en) 2005-04-15
AP1595A (en) 2006-04-12
WO2003000225A2 (fr) 2003-01-03
ATE290366T1 (de) 2005-03-15
AP2003002927A0 (en) 2003-12-31
NO20035581D0 (no) 2003-12-15
FR2826274B1 (fr) 2003-09-26
CO5540278A2 (es) 2005-07-29
US20070014857A1 (en) 2007-01-18
US20040142029A1 (en) 2004-07-22
MA27042A1 (fr) 2004-12-20
BG108458A (bg) 2005-02-28
SV2003001098A (es) 2003-03-18
CN1239149C (zh) 2006-02-01
SK15922003A3 (sk) 2004-05-04
FR2826274A1 (fr) 2002-12-27
AR036096A1 (es) 2004-08-11
BG66314B1 (bg) 2013-04-30
NZ530042A (en) 2005-09-30
CN1529585A (zh) 2004-09-15
NO332258B1 (no) 2012-08-13
EA200400061A1 (ru) 2004-06-24
UY27341A1 (es) 2003-01-31
AU2002329311B2 (en) 2007-02-01
CA2452239A1 (fr) 2003-01-03
HUP0400799A2 (hu) 2004-08-30

Similar Documents

Publication Publication Date Title
MY134340A (en) Pharmaceutical formulation having a masked taste and method for the production thereof
WO2002101412A3 (en) Spray freeze-dried compositions
WO2003043586A3 (en) Compositions for sustained action product delivery
BR0103033A (pt) Partìculas farmacêuticas de sabor mascarado
WO2002045684A3 (en) Rapidly dispersing pharmaceutical composition comprising effervescent agents
CA2336570A1 (en) Croscarmellose taste masking
WO2001085212A3 (en) Drug delivery systems for photodynamic therapy
WO2003082247A3 (en) Drug microparticles
HUP0303891A3 (en) Pharmaceutically active piridine derivatives, process for their preparation and pharmaceutical compositions containing them
WO2003035051A3 (en) The use of proton sequestering agents in drug formulations
PL367447A1 (en) Novel 2h-pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient
AU2001262011A1 (en) A complex between folic acid and polysaccharides, its preparation method and a pharmaceutical composition comprising said complex as active component
IL150528A0 (en) Ibuprofen containing active agent preparation
BG108516A (en) Pharmaceutical formulation
CA2445519A1 (en) Method for manufacturing a low dose pharmaceutical composition
AU2002358676A1 (en) Hydroxyphenyl-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
WO2004017943A3 (en) Non-vesicular cationic lipid formulations
WO2005065639A3 (en) Novel pharmaceutical compositions
UA89349C2 (uk) Таблетка без покриття, яка містить оланзапін, та спосіб її одержання
HUP0600084A2 (en) Pharmaceutical compositions containing ascorbic acid derivatives, methods of production of the active ingredient
EP1059304A4 (en) NOVEL POLYSACCHARIDE DERIVATIVES, PROCESS FOR PRODUCING THE SAME, AND MEDICINAL COMPOSITIONS CONTAINING THESE NEW DERIVATIVES AS ACTIVE INGREDIENT
WO2003030862A3 (en) Anaesthetic compositions and method for their administration
CA2429793A1 (en) Interferon therapeutic effect enhancer
EP1634585A4 (en) MEDICINAL PRODUCTS CONTAINING DELAYED MICROTEIL, PROCESS FOR ITS PREPARATION AND MICROPARTICLE CONTAINING PREPARATION
CA2382359A1 (en) Pharmaceutical preparation containing nanosol